Theralizumab, CAS [[906068-56-2]]

Product Overview

• Article Name: Theralizumab, CAS [[906068-56-2]]
• Biozol Catalog Number: TGM-T77093
• Supplier Catalog Number: T77093
• Alternative Catalog Number: TGM-T77093-1MG,TGM-T77093-5MG,TGM-T77093-10MG,TGM-T77093-25MG,TGM-T77093-50MG
• Manufacturer: TargetMol
• Category: Biochemikalien
• Alternative Names: TGN1412 , TAB-08 , TABO8

Product Description

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.

Product Properties

• Purity: 95.00%
• CAS Number: [906068-56-2]
• Target: Immunology/Inflammation related|||Others